−60KRW
−4.67 BKRW
73.13 BKRW
60.84 M
About LABGEN
Sector
Industry
CEO
Seung-Hyun Jin
Website
Headquarters
Seongnam-si
Employees (FY)
213
Founded
2002
ISIN
KR7084650001
FIGI
BBG004RKW1T8
LabGenomics Co., Ltd. engages in the provision of vitro diagnostic products and services. Its products include sample and bioinformatics analysis, diagnostic checks, and other products. The company was founded on March 29, 2002 and is headquartered in Seongnam-si, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 084650 is 2530.00 KRW — it has decreased by 2.32% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange LABGEN stocks are traded under the ticker 084650.
One year price forecast for LABGEN has a max estimate of 5000.00 KRW and a min estimate of 5000.00 KRW.
LABGEN revenue for the last quarter amounts to 21.20 B KRW despite the estimated figure of 27.70 B KRW. In the next quarter revenue is expected to reach 22.30 B KRW.
Yes, you can track LABGEN financials in yearly and quarterly reports right on TradingView.
Like other stocks, 084650 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LABGEN stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 213.00 employees. See our rating of the largest employees — is LABGEN on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LABGEN EBITDA is −963.82 M KRW, and current EBITDA margin is −1.23%. See more stats in LABGEN financial statements.